EHC250516C115000
- 2.90
- +0.45+18.37%
Encompass Health Newsroom
Encompass Health's Earnings Call Highlights Growth and Challenges
Encompass Health Is Maintained at Buy by UBS
Encompass Health to Participate in BofA Securities 2025 Healthcare Conference
Encompass Health Is Maintained at Outperform by RBC Capital
Encompass Health Analyst Ratings
Encompass Health Beats Q1 Earnings Estimates, Ups '25 EPS View
Encompass Health Price Target Raised to $135.00/Share From $116.00 by Truist Securities
Analysts' Top Healthcare Picks: Encompass Health (EHC), Evaxion Biotech (EVAX)
Deutsche Bank Raises Price Target on Encompass Health to $130 From $118, Keeps Buy Rating
William Blair Maintains Encompass Health(EHC.US) With Buy Rating
Express News | Encompass Health Corp : RBC Raises Target Price to $125 From $110
Encompass Health Corporation Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next
BofA Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $128
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating
Earnings Call Summary | Encompass Health(EHC.US) Q1 2025 Earnings Conference
Top Gap Ups and Downs on Friday: GOOGL, TMUS, GILD and More
Marijuana Stock Movers For April 25, 2025
Shares of Encompass Health Rise After Strong 1Q; Company Lifts Full-Year Guidance
Encompass Health Up Nearly 11%, On Track for Highest Close Since July 1998 -- Data Talk
Encompass Health Is Maintained at Overweight by Keybanc